| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.33 |
9e-16 |
| mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.25 |
9e-10 |
| mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
5e-08 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
6e-08 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
1e-07 |
| mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
4e-07 |
| mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
9e-07 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-06 |
| mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-06 |